BSE filing, NSE: LUMAXTECH. Summary written from the filing by ALFA Finder's alert engine.
Lumax Auto Technologies Ltd: key numbers
- Share price
- ₹2,051.70
- Market cap
- ₹13,984 Cr
- Revenue (annual)
- ₹4,870 Cr
- Net profit (annual)
- ₹278.9 Cr
- P/E (TTM)
- 38.5×Sector 30.9×
- Promoter holding
- 55.98%+0.00% QoQ
- FII holding
- 8.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lumax Auto Technologies Ltd
All →Lumax Auto Technologies Earnings Call Transcript: Key Takeaways
Lumax reports record revenue surpassing ₹1,500 Cr milestone, driven by robust automotive sector recovery.
- Call
- Guides 20% growth
Lumax Auto Technologies Investor Presentation: Key Takeaways
Q2FY27 revenue INR 1,556 Cr (+35% YoY), PAT INR 117 Cr (+50%), EBITDA margin flat at 14.7%. Strategy anchored on a 20% revenue CAGR North Star through FY31e.
- Call
- Guides 20% growth
Lumax Auto Technologies Results Update
Lumax Auto Technologies released investor highlights for Q2 and H1 FY27, showing revenue of Rs 1,556 Crore in Q2 (up 35% YoY). PAT before minority interest rose 50% to Rs 117 Crore.
Lumax Auto Technologies Q2 FY27 Results: Net Profit ₹116.7 Cr, Up 50.4% YoY
Lumax Auto Technologies Ltd reported revenue from operations of ₹1,556 Cr (+34.5% YoY) and net profit of ₹116.7 Cr (+50.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹116.7 Cr · +50.4% YoY
Lumax Auto Technologies Other Announcement
Lumax Auto Technologies Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Lumax Auto Technologies Management Change
Lumax Auto Technologies announced the superannuation of Sanjay Bhagat, Sr. EVP, and the resignation of CTO Satish Sundaresan from senior management effective September 2026.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.